MedPath

Cerebral Perfusion During Neonatal Cardiac Surgery

Not Applicable
Completed
Conditions
Congenital Heart Defects
Hypoplastic Left Heart Syndrome
Aortic Coarctation
Interventions
Procedure: Deep Hypothermic Circulatory Arrest
Procedure: Antegrade Cerebral Perfusion
Registration Number
NCT01032876
Lead Sponsor
UMC Utrecht
Brief Summary

Neonates with a congenital heart defect are often in need of early cardiac surgery. In complex congenital heart defects, cardiopulmonary bypass is usually employed, with or without deep hypothermic circulatory arrest (DHCA). The brain is especially vulnerable to ischemic injury, which puts neonates undergoing complex operations at high risk of neurodevelopmental disorders. Selective antegrade cerebral perfusion (ACP) instead of DHCA during these complex operations may contribute to less cerebral damage, but literature is not conclusive on this issue.

Therefore, the investigators will perform a randomised controlled trial comparing DHCA and ACP in neonatal aortic arch reconstructions, focusing on cerebral damage and neurological outcome.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  • Aortic arch reconstruction (diagnosis of hypoplastic left heart syndrome, hypoplastic aortic arch, severe coarctation and/ or interrupted aortic arch)
  • Infants <4 months old
Exclusion Criteria
  • Anticipated arch reconstruction time longer than 60 minutes
  • Sedation and intubation especially for the pre-operative MRI-scan of this research project
  • Participation in another clinical trial
  • Failure of data collection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Deep Hypothermic Circulatory ArrestDeep Hypothermic Circulatory Arrest-
Antegrade Cerebral PerfusionAntegrade Cerebral Perfusion-
Primary Outcome Measures
NameTimeMethod
New or worsened lesions on postoperative MRI-scan (as compared to pre-operative scan).Approximately 1 week postoperatively
Secondary Outcome Measures
NameTimeMethod
Mortality within 30 days30 days postoperatively

Trial Locations

Locations (1)

UMC Utrecht

🇳🇱

Utrecht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath